AREV Life Sciences Global AREVF Stock
AREV Life Sciences Global Price Chart
AREV Life Sciences Global AREVF Financial and Trading Overview
| AREV Life Sciences Global stock price | 0.0005 USD |
| Previous Close | 0.0005 USD |
| Open | 0.01 USD |
| Bid | 0.005 USD x 0 |
| Ask | 0.02 USD x 0 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.0005 - 0.01 USD |
| Volume | 10K USD |
| Avg. Volume | 0 USD |
| Market Cap | 15.88K USD |
| Beta (5Y Monthly) | 4.953 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AREVF Valuation Measures
| Enterprise Value | 159.52K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.2029407 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 22.128 |
| Enterprise Value/EBITDA | -0.928 |
Trading Information
AREV Life Sciences Global Stock Price History
| Beta (5Y Monthly) | 4.953 |
| 52-Week Change | -95.00000000000000000000000000000000% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.0005 USD |
| 50-Day Moving Average | 0.0005 USD |
| 200-Day Moving Average | 0.003825 USD |
AREVF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 31.76M |
| Float | 16.83M |
| Short Ratio | N/A |
| % Held by Insiders | 47.40% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2702.42% |
| Gross Margin | -177.055% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.42% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 7.21K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -12764 USD |
| EBITDA | -171964 USD |
| Net Income Avi to Common (ttm) | -239541 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.82K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 145.46K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.05 |
| Book Value Per Share (mrq) | -0.02681538 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -151387 USD |
| Levered Free Cash Flow (ttm) | -83095 USD |
Profile of AREV Life Sciences Global
| Country | United States |
| State | BC |
| City | Coquitlam |
| Address | 18 - 91 Golden Drive |
| ZIP | V3K 6R2 |
| Phone | 604 803 8439 |
| Website | https://www.arevlifesciences.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.
Q&A For AREV Life Sciences Global Stock
What is a current AREVF stock price?
AREV Life Sciences Global AREVF stock price today per share is 0.0005 USD.
How to purchase AREV Life Sciences Global stock?
You can buy AREVF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AREV Life Sciences Global?
The stock symbol or ticker of AREV Life Sciences Global is AREVF.
Which industry does the AREV Life Sciences Global company belong to?
The AREV Life Sciences Global industry is Drug Manufacturers - Specialty & Generic.
How many shares does AREV Life Sciences Global have in circulation?
The max supply of AREV Life Sciences Global shares is 31.76M.
What is AREV Life Sciences Global Price to Earnings Ratio (PE Ratio)?
AREV Life Sciences Global PE Ratio is now.
What was AREV Life Sciences Global earnings per share over the trailing 12 months (TTM)?
AREV Life Sciences Global EPS is -0.01 USD over the trailing 12 months.
Which sector does the AREV Life Sciences Global company belong to?
The AREV Life Sciences Global sector is Healthcare.